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Summary. A purified lectin (MLI) from Viscum album 
was used to test whether peripheral monocytes from 
human blood can be activated for the production of tumour 
necrosis factor (TNF). Cytotoxic activity was detected in 
the supernatant ofMLI-stimulated monocyte cultures. This 
cytotoxic activity was completely inhibited by monoclonal 
antibodies to TNF(x. Small amounts of soluble TNF protein 
were measured in a TNFc~-specific enzyme-linked immu- 
nospecific assay system. Strong expression of TNFc~ 
mRNA was induced in human monocytes as well as in 
macrophage cultures from C3H/HeJ mice having a low 
response to endotoxin after 2 h of stimulation. Both chains 
of the MLI were found to induce TNF mRNA equally well 
in human monocytes. In macrophages of endotoxin-low- 
responder mice the toxic A chain was a better inducer of 
TNF mRNA than the galactose-specific lectin B chain. 
Thus, MLI has immnnomodulating effects in activating 
monocytes/macrophages for inflammatory esponses. 
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Introduction 
Stimulation of the reticular endothelial system and espe- 
cially of macrophages seems to be important in the defence 
of an organism against infections and tumours. Analysis of 
the mechanism and the structures involved in such activa- 
tion of mononuclear phagocytes is required for the 
development oftherapeutic applications. A great variety of 
biochemically different structures are already known for 
macrophage activation. Classical activating structures are 
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bacterial lipopolysaccharide and interferon- 7 (IFNT) when 
the production of inflammatory monokines like tumour 
necrosis factor (TNF) or interleukin-1 (IL-l) is used as a 
parameter of macrophage activation [1, 3, 19]. Muramyl- 
dipeptide [23] and polyinosinic.polycytidylic acid [25] are 
also widely used for macrophage activation. Purified lipo- 
arabinomannan from Mycobacterium tuberculosis has re- 
cently been reported to cause the release of TNF from 
human blood monocytes [21]. From plants, extracts from 
Radix angelicae, Radix bupleuri, Rhizoma cnidii and Cor- 
tex cinnamomi [14] and acidic arabinogalactan, a highly 
purified polysaccharide from cell cultures of Echinacea 
purpurea [17], were all able to activate macrophages ffec- 
tively for TNF production. 
For centuries the mistletoe Viscum album has been used 
therapeutically. In a series of papers it has been demon- 
strated that the main lectin from European mistletoe (mis- 
tletoe lectin I, MLI) belongs to the so-called toxic lectins 
besides ricin, abrin, modeccin and PCL, the lectin from 
Phoradendron californicum (for review see [6, 9]. These 
lectins all consist of an A and a B chain. The B chain of 
MLI is a galactose-specific lectin and the A chain acts 
enzymatically. Some years ago both chains were prepared 
without loss of biological activity [8, 22]. Together with 
Endo and his group we were able to show that the A chain 
of MLI is similar to the A chain of ricin: an N-glycosidase 
that releases adenine from position 4324 of 28S subunits of 
ribosomal RNA, thus serving as the toxophoric omponent 
[7]. Testing the biological activities of both A and B chains 
showed that the A chain is a mitogen. Moreover, it releases 
IL-1 and IL-2 from human lymphocytes [11]. The B chain 
activates macrophages both by direct interaction and by 
release of a macrophage-stimulating factor. Recently, 
Hajto et al. [13] published an account of a modulating 
potency of mistletoe xtracts, which they explain by the 
activity of the B chain of MLI. 
This investigation tested whether purified MLI or the 
isolated A or B chain was able to activate human blood 
monocytes or murine macrophages directly for TNF 
mRNA expression and TNF production. 
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Materials and methods 
Reagents. Lectin I (MLI) from Viscum album was prepared in the 
Staatliches Institut für Immunpräparate und Nährmedien, Berlin, FRG, 
according to the method escribed by Ziska et al. [26]. The MLI prepara- 
tion (charge no. 000 788) that was used for all experiments described in 
this manuscript contained 130 pg endotoxin/gg protein. A chain and 
B chain of MLI were prepared according to Franz et al. [8], using 
modifications by Pfüller et al. (manuscript in preparation). The A and 
B chain preparations contained 440 pg and 500 pg endotoxin/gg pmtein, 
respectively, as determined by Dr. R. Urbaschek, Mannheim according 
to the method escribed in Ditter et al. [5]. Glutaraldehyde-fixed Staphy- 
lococcus aureus cells (Pansorbin, Calbiochem, Behring Diagnostics, La- 
Jolla, California) were used as a 0.1% (w/v) suspension. Recombinant 
human interferon 7 (IFNT) was provided by Dr. Adolf, Ernst Boehringer 
Institut für Arzneimittelforschung, with a specific activity of 
2 × 107 U/mg. Lipopolysaccharide from Salmonella minnesota nd Poly- 
myxin B were purchased foto Sigma, Deisenhofen, FRG. Recombinant 
human TNFc~ (rhTNF) was supplied by Knoll/BASF AG, Ludwigshafen, 
FRG; the specific activity was 9 x 107 U/mg protein as measured in the 
bioassay. Monoclonal anti-rhTNF antibodies were obtained by fusing 
mouse spleen cells, from a mouse immunized with rhTNF, with 
AG8.653 myeloma cells by the polyethyleneglycol method and screening 
the hybridoma supernatants for neutralizing activity. The anti-TNF anti- 
bodies were used as a 1 : 1000 dilution of ascites fluid. The monoclonal 
anti-lymphotoxin a tibody clone 9B9 and the monoclonal anti-rhTNF 
antibody clone 199 were a generous gift of Dr. A. Möller BASF, Lud- 
wigshafen, FRG. Purified antibodies were used at a final concentration f 
1 gg/rel. 
Culture medium. The culture medium used was RPMI- t640 (Gibco) with 
10% heat-inactivated fetal calf serum (Gibco), and gentamycin 
(50 gg/tal) (Sigma) unless tated otherwise. 
Preparation of cells. Human peripheral blood mononuclear leucocytes 
were prepared from buffy coats of healthy blood donors by Ficoll-Hy- 
paque density gradient centrifugation [2]. For the preparation of the 
adherent cell fraction the cells (3 x 106 cells/ml) were seeded in 24-well 
plastic tissue-culture plates (Falcon) and incubated for 2 h at 37 ° C in a 
humid atmosphere containing 5% CO2. Nonadherent cells were removed 
by washing the cultures three times with culture medium. The remaining 
cell fraction consisted of over 90% monocytes as determined by mor- 
phology and phagocytosis. C3H/HeJ mice, having a low response to 
lipopolysaccharide, were purchased from the Hannoversche Ver- 
suchstieranstalt, Hannover, FRG. Peritoneal exudate cells were induced 
by injecting 1 ml phosphate-buffered saline i. p. 16 h before the pefitone- 
al cells were washed out with cold medium. Samples of 5 x 106 peritone- 
al exudate cells were seeded in 24-well tissue-culture plates and the 
adherent fraction was obtained as described above. 
TNF assay systems. The cytotoxicity assay for TNF was carried out on 
sensitive L929 mouse fibrosarcoma cells (2 × 104 cells/0.2 ml culture) in 
the presence of actinomycin D (2 gg/tal) (Sigma). The cultures contained 
serial dilutions of TNF samples. After 20 h of culture the surviving cells 
were fixed and stained with crystal violet (0.5% crystal violet, 3% v/v 
formaldehyde, 0.17% NaC1, 22% ethanol) for 15 min. Excess dye was 
washed oft with water and the remaining dye solubilized in 33% acetic 
acid. Absorbance was measured at 540 nm. Concentrations of TNF are 
expressed as units indicating the reciprocal dilution of the samples in 
triplicate at which 50% suawival was measured. Sensitivity of this assay 
varied between 1ng and 0.5 ng rhTNF/ml. 
TNF activity was also measured by an enzyme-linked immu- 
nospecific assay (ELISA) as described recently [18]. Plates (96-well 
flat-bottom, Titertek Immuno Assay Plate, Flow Laboratories, Mecken- 
heim, FRG) were coated with affinity-purified (protein A-diasorb, Di- 
agen, Düsseldorf, FRG), polyclonal rabbit anti-rhTNF antibodies 
5 gg/tal in NaHCO3 buffer (0.05 M, pH 9) for 16 h at 4 ° C. Serial dilu- 
tions of the test samples in phosphate buffer (0.1 M, pH 7.5, 2% EDTA, 
1% bovine serum albumin) were applied to the plates for 2 h at room 
temperature after blocking with 1% bovine serum albumin in phosphate- 
buffered saline (PBS) for 2 h at room temperature. Plates were washed 
with PBS containing 0.05% Tween, and biotin (Sigma, Deisenhofen, 
FRG)-conjugated affinity-purified (protein-A-diasorb, Diagen, Düssel- 
dorf, FRG) polyspecific rabbit anti-rhTNF antibodies (2.7 gg/ml) were 
added to the wells for 1.5 h at room temperature. After extensive washing 
with PBS containing 0.05% Tween, streptavidin-peroxidase complex 
(BRL, Karlsruhe, FRG) (1 : 2000 diluted) was applied for 30 min at mom 
temperature. The plates were washed again with PBS containing Tween 
(0.05%) and the substrate solution [3,3',-5,5'-tetramethylbenzidine, 
Miles Scientific, München, FRG, 10 mg in 100 ml sodium acetate/citric 
acid buffer (0.1 M, pH 4.9) and 14.7 btl 30% H202] was added to the 
complex. The reaction was stopped with 2 M H2SO4 and the absorption 
measured at 450 nm. The absorption curves obtained with the test 
samples were compared to a standard curve obtained with rhTNF and the 
TNF content was expressed as ng/ml. The sensitivity of this TNF assay 
was 0,5 ng rhTNF/ml. 
Immunocytochemistry. Thecells were fixed at room temperature with 
acetone for 20 min and treated with methanol containing 0.5% H202 for 
3 min. Cell-associated TNF was determined with monoclonal mouse 
anti-rhTNF antibodies (clone 199) and peroxidase-coupled rabbit anti- 
(mouse Ig)antibodies (Sigma). The substrate 3-amino-9-ethylcarbazole 
(AEC, Sigma) was used. Controls were stained with an isotype-matched 
irrelevant first antibody. 
RNA extraction and dot-blot analyses. The procedure has been described 
in detail recently [4]. Cells (10 »- 106/culture) were solubilized with 1 ml 
7.6 M guanidine/HC1 in 0.1 M potassium acetate buffer pH 5, and DNA 
was sheared by aspirating five times through a 21-gauge needle. Ethanol 
(0.6 ml 95%) was added and RNA precipitated at-20°C for 12 h. RNA 
was pelleted by 20 min, centrifugation at 15 000 g, the pellet dissolved in 
150gl 15% formaldehyde in water and 150 gl 20xSSC [1 xSSC 
(standard saline citrate) is 0.15 M sodium chloride, 0.015 M sodium 
citrate] was added. The solution was heated 15 min at 50°C and chilled 
on ice. Aliquots or serial dilutions were applied to nylon filters (Compas, 
Genofit, Heidelberg, FRG) prewetted with water and then with 
10xSSC. The RNA was fixed on the nylon filters by exposure to 
ultraviolet light for 2 min and hybridization was performed according to 
the method escribed in detail by Khandjian [15] at 42 ° C in the presence 
of dextran sulphate. The filters were washed twice under high-stringency 
conditions (65 ° C, 30 min, 2 x SSC containing 1% sodium dodecyl sul- 
phate). Probes were labelled with [32p]dGTP and [32p]dCTP (Amersham, 
Frankfurt, FRG, specific activity 3000 Ci/mmol) by the random-pfimer 
method using a hexamer (Pharmacia, Freiburg, FRG). 
The TNF cDNA probe was a 700-base-pair(bp) Eco RI fragment of 
the coding region of human TNF. The human ~-actin cDNA probe was 
described by Moos and Gallwitz [20] and consists of a 560 bp Sal I- 
Eco RI cDNA fragment. The routine [~-actin cDNA probe was a 2000-bp 
Pst I fragment of the mouse [3-actin gene. For quantitative analysis the 
developed X-ray films were densitometrically scanned and the absorp- 
tion normalized to the absorption measnred in the actin-hybridized fil- 
ters. 
Results 
Human per ipheral  b lood monocytes  were st imulated with 
ML I  in order to determine whether  the pur i f ied protein 
preparat ion was able to act ivate the monocytes  for TNF  
production.  Concentrat ions of  more than 1 gg/ta l  ML I  in- 
duced release of  cytotoxic  act iv ity (Table 1). In combina-  
t ion with human interferon 7 (IFNy) the ML I  preparat ion 
was act ive at 10 ng/ml  and more. When supernatants of  
ident ical ly  st imulated cultures were tested in the TNF-spe-  
ci f ic EL ISA  system, TNF  was detected at the highest  con- 
centrations of  ML I  used for st imulation. A t  the concentra-  
t ions used in these exper iments  the lect in i tself  did not 
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Table 1. Induction of tumour necrosis factor (TNF) release in culture of 
human monocytes by mistletoe l ctin I (MLI) 
Stimulus TNF a 
Bioassay (unit) ELISA (ng/ml) 
MLI 
10 gg/ml 256 0.8 
1 gg/tal 128 <0.5 
100 ng/ml 4 <0.5 
10 ng/ml 4 <0.5 
1 ng/ml 2 <0.5 
0.1 ng/ml 2 <0.5 
MLI + IFNy 100 U 
10 gg/mt >256 0.8 
1 gg/ml 256 0.5 
100 ng/ml 64 <0.5 
10 ng/ml 18 <0.5 
1 ng/ml 8 <0.5 
0.1 ng/ml 8 <0.5 
IFN 7 100 U 8 <0.5 
Staph. aureus 10 gg/ml 16 1.5 
Unstimulated 2 <0.5 
123 
i 
45 
hTNF 
BActin 
a Cytotoxic activity and TNF content were measured in the supernatant 
of monocyte cultures after 16 h of incubation. ELISA, enzyme-linked 
immunospecific assay; IFN 7, interferon 7 
Table 2. Inhibition of cytotoxic activity with monoclonal ntibodies to 
rhTNF 
Fig. 1. Northern blot analysis of mRNA extracted from human mono- 
cytes cultured for 2 h without stimulus (Iane 1), Staph. aureus 10 gg/tal 
(lane 2), mistletoe l ctin I (MLI) 10 ~tg/ml (lane 3), interferon Y (IFNy) 
10 U (lane 4) or MLI 10 gg/ml plus IFNy100 U (lane 5) probed with 
either a human tumour necrosis factor (hTNF) or a human [3-actin cDNA 
probe 
Stimulus Antibody TNF a (units) 
TNF 10 ng/ml 
MLI supernatants b 
MLI + IFNy supernatants b 
- 64 
c~TNF <2 
c~LT 64 
- 32 
c~TNF <2 
c~LT 32 
- 32 
ŒTNF <2 
«LT 32 
a Cytotoxic activity was determined in the bioassay in the presence and 
absence of monoclonal ntibodies toeither hTNF or recombinant human 
lymphotoxin (LT) 
b Supernatants of monocyte cultures stimulated with MLI (10 gg/ml) or 
MLI (10 gg/ml) plus IFN 7 (100 U/ml) were tested in the TNF bioassay 
interfere with either the TNF bioassay or the ELISA sys- 
tem (data not shown). Activation of monocytes was repro- 
ducible but varied with monocytes from different donors. 
Monoclonal antibodies to TNF and lymphotoxin were 
used to determine the contribution from TNF and from 
lymphotoxin to the cytotoxic activity measured in the bio- 
assay. As can be seen in Table 2 antibodies to rhTNF 
completely neutralized the cytotoxicity of supernatants of
monocytes timulated with MLI or MLI plus IFNy. In 
contrast, neutralizing antibodies to recombinant human 
lymphotoxin did not reduce the activity of the cytotoxic 
supernatants. This indicates that the cytotoxic activity can 
completely be attributed to TNF. 
When RNA was extracted from human monocytes that 
had been stimulated for 2 h with MLI, TNF mRNA was 
Table 3. Inhibition of TNF mRNA expression by the addition of polymy- 
xin B for stimulation 
Stimulus Polymyxin Ba TNF signal b Inhibition 
(absorbance) (%) 
LPS - 27.06 
+ 9.77 63.9 
Staph. aureus - 26.19 
+ 20.11 23.3 
MLI - 26.61 
+ 23.52 11.6 
a mRNA extracted from human monocytes that had been cultured for 
2 h either with lipopolysaccharide (LPS) of S. minnesota (50 ~tg/ml), 
Staph. aureus (10 gg/ml) or MLI (10 gg/ml) in the absence (-) or pres- 
ence (+) of polymyxin B (20 gg/tal) was subjected to dot-blot analysis. 
Each stimulant together or without polymyxin B was kept at 37 ° C for 
30 min before stimulation of the cells 
b The absorbance ofthe total area of the signal obtained after hybrid- 
ization with the TNF cDNA probe was normalized to the signal obtain- 
ed with the actin cDNA probe on the same filter 
clearly detectable y Northern blot analysis (Fig. 1). The 
signal induced by MLI stimulation of the monocytes was at 
least as strong as after stimulation with Staph. aureus. 
Since the MLI preparation contained endotoxin, the 
monocyte activation could be due to this endotoxin even 
though the experimental system is not very sensitive to 
lipopolysaccharide [17]. To exclude lipopolysaccharide 
contamination of MLI as the activating signal, monocytes 
were cultured in the presence of polymyxin B. Dot-blot 
analysis demonstrated that Staph. aureus- and MLI-acti- 
vated monocytes were rather esistant to the effect of poly- 
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Fig. 2. Northern blot analysis of mRNA extracted from mouse 
(C3H/HeJ) peritoneal macrophages cultured for 2 h with either tipopoly- 
saccharide of S. minnesota 10 gg/ml (lane 1), MLI 10 gg/ml (lane 2), 
Staph. aureus 10 gg/tal (lane 3) or without stimulus (lane 4) probed with 
either a hTNF or a murine [5-acting cDNA probe 
Fig. 4. Northem b[ot analysis of mRNA extracted from mouse 
(C3H/HeJ) peritoneal macrophages cultured for 2 h with either MLI 
10 gg/tal (lane 1), A chain 10 gg/tal (lane 2), B chain 10 p.g/ml (lane 3) 
or lipopolysaccharide of S. minnesota 10 [xg/ml (lane 4) probed with 
either a hTNF or a routine 13-actin cDNA probe 
12 345  
hTN F 
ßActin 
Fig. 3. Northern blot analysis of mRNA extracted from human mono- 
cytes culmred for 2 h without stimulus (lane 1), MLI 10 gg/tal (lane 2), 
A chain 10 ~tg/ml (lane 3), B chain 10 pog/ml ( ane 4) or Staph. aureus 
10 gg/tal (lane 5) probed with either a hTNF or a human ~-actin cDNA 
probe 
myxin B whereas lipopolysaccharide activation of the 
monocytes was clearly reduced in the presence of polymy- 
xin B (Table 3). 
To exclude further a stimulating effect of lipopolysac- 
charide macrophages of mice having a low response to 
lipopolysaccharide (C3H/HeJ) were stimulated with MLI. 
As can be seen in Fig. 2 only Staph. aureus (lane 3) and 
MLI (lane 2) but not lipopolysaccharide (lane 1) were able 
to induce the expression of TNF mRNA in these cells, 
demonstrating the direct activating effect of MLI on mac- 
rophages. 
Monocyte cultures were stimulated with MLI and in 
parallel with the isolated A chain and B chain. As can be 
seen in Fig. 3 all three agents were equally able to induce 
TNF mRNA. Both chains were also active on peritoneal 
exudate cells of C3H/HeJ mice (Fig. 4). The A chain, how- 
ever, induced a much stronger TNF mRNA expression i  
murine macrophages than did the B chain. 
Culture of peripheral blood lymphocytes with either the 
A or B chain of MLI for 16 h clearly led to production of 
cell-associated TNF (Fig. 5). No positive staining was ob- 
tained in unstimulated cells or cells stained with an ir- 
relevant first antibody for control. 
Discussion 
The biochemical characterization f a biologically active 
component of Viscum album made it possible to analyse 
the immunomodulary mechanisms of this substance on the 
molecular level. Purified MLI, one of three known mis- 
tletoe lectins consisting of two disulphide-linked subunits, 
was tested for its monocyte activating capacity in vitro. 
This investigation was prompted by the observation that 
MLI given intraperitoneally produced C-reactive protein in 
mice [10]. 
Generation of cytotoxic activity was found in super- 
natants of human monocyte cultures timulated with MLI. 
The levels of cytotoxic activities induced by MLI varied 
from blood donor to blood donor as already noted with 
other stimuli [18]. The stimulant i self did not account for 
the observed cytotoxic activity in the TNF bioassay, since 
the amount of MLI used for monocyte stimulation did not 
itself affect the viability of the TNF indicator cells. In 
addition, soluble TNF protein was detectable in the TNF~- 
specific ELISA system after MLI stimulation of the mono- 
cytes. The addition of IFNy only slightly increased the 
amount of TNF released from monocytes indicating that 
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Fig. 5. Peripheral b ood monocytes 
were cultured for 12 h without stimu- 
lant (a), or with either MLI 10 gg/ml 
(b), A chain 10 gg/ml (c), or B chain 
10 gg/tal (d) and stained for cell-as- 
sociated TNE The photomicrographs 
show the stained cells at a 1000 x
magnification 
MLI like IFNy provides a stimulating signal for TNF pro- 
duction rather than a trigger for TNF release. The induction 
of TNF mRNA by 10 gg/tal MLI was comparable to the 
signal induced by 100 U IFNy in the monocyte activating 
system. The relative insensitivity of the system to stimula- 
tion with lipopolysaccharide [18] already indicated that 
endotoxin contamination was not responsible for the ob- 
served monocyte activation. Pretreatment of MLI with 
polymyxin B and the presence of polymyxin B during 
stimulation of the monocyte cultures did not abolish the 
activating capacity of MLI. Furthermore, peritoneal exu- 
date macrophages from C3H/HeJ, mice having a low re- 
sponse to lipopolysaccharide, were activated by MLI for 
TNF mRNA expression. Thus, the contaminating en- 
dotoxin did not account for the stimulatory capacity of 
MLI, which must then be an intrinsic activity of the MLI 
molecule. It is possible, therefore, that the release of medi- 
ators like TNF is involved in the mechanism of the impres- 
sive toxicity of MLI after intraperitoneal pplication. This 
is in agreement with recent histochemical results [12]. 
After application of lethal doses of MLI into mice the 
glycogen disappeared completely from hepatocytes, and 
the activities of both thiamine phosphatase and non-specif- 
ic alkaline phosphatase increased. However, when we in- 
jected a lethal dose of MLI into C3H/HeJ mice having a 
low response to endotoxin and injected at the same time a 
large dose of murine TNF-neutralizing monoclonal anti- 
body, no protective ffect was achieved by these antibod- 
ies. No difference in the behaviour of the animals nor in the 
histological evaluation of sections from spleen, liver, kid- 
ney or lung was seen. Neither TNF nor interleukin-6 was 
detectable in serum or in supernatants of cultured peritone- 
al exudate cells from these mice (unpublished results). 
Experiments o determine whether the enzymatic activ- 
ity of the MLI A chain and/or the carbohydrate-binding 
activity of the MLI B chain was responsible for the mono- 
cyte activation demonstrated that both chains idependently 
were able induce TNF mRNA. The expression of IL-I~ 
mRNA was also strongly enhanced (data not shown). Ex- 
periments with peritoneal exudate cells from mice having a 
low response to endotoxin showed that TNF mRNA ex- 
pression by the toxic A chain of MLI was stronger than by 
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the galactose-specific B chain. This indicated that either 
the endotoxin contamination, although by itself inactive, 
contributed and synergized with the MLI B chain or that 
stimulation requirements for murine macrophages are 
quantitatively different from human monocytes. The possi- 
bility of the MLI B chain binding to a D-galactose-contain- 
ing receptor structure of the monocyte/macrophage might 
give further insight in the activation process and the in- 
volved membrane structures. Considering a recent report 
on the activation of human blood monocytes by an 
oligosaccharide from Viscum album extracts [16], we can 
not exclude the possibility that the carbohydrate moiety of 
MLI also has a biological activity. In view of the therapeu- 
tic application of MLI or other lectins from Viscum album 
(MLII, MLIII) in cancer treatment, here are at least three 
possible opportunities: (a) direct killing of the malignant 
cells by the cytotoxic lectin, (b) induction of endogenous 
mediators of the immune system, and (c) use of the 
A chain of MLI as an alternative component for the prepa- 
ration of immunotoxins [24]. 
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